diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients suspected of having diabetes or diabetes (HbA1c > 6.5%) Who, written consent for participation in this study was obtained
Exclusion criteria
Exclusion criteria: Dialysis patients Patients with insulin therapy Patients who have severe diabetic nephropathy(eGFR<30) Patients who can not properly operate the device to be used Patients who the physician determines that it is inappropriate to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c 6 months after initiation of intervention | — |
Countries
Japan
Contacts
Nagoya University Graduate School of Medicine Endocrinology and Diabetes